Malignant mesothelioma
BWS Robinson, AW Musk, RA Lake - The Lancet, 2005 - thelancet.com
Malignant mesothelioma is an aggressive, treatment-resistant tumour, which is increasing in
frequency throughout the world. Although the main risk factor is asbestos exposure, a virus …
frequency throughout the world. Although the main risk factor is asbestos exposure, a virus …
Malignant pleural mesothelioma: history, controversy, and future of a man-made epidemic
Asbestos (Greek, inextinguishable) is the term of a family of naturally occurring minerals that
have been used in small scale since ancient times. Industrialization demanded increased …
have been used in small scale since ancient times. Industrialization demanded increased …
L1CAM in human cancer
P Altevogt, K Doberstein, M Fogel - International journal of …, 2016 - Wiley Online Library
L1 cell adhesion molecule (L1CAM) is one of the first neural adhesion molecules described
with important functions in the development of the nervous system. Subsequent work …
with important functions in the development of the nervous system. Subsequent work …
Global Gene Expression Profiling of Pleural Mesotheliomas: Overexpression of Aurora Kinases and P16/CDKN2A Deletion as Prognostic Factors and Critical …
F López-Ríos, S Chuai, R Flores, S Shimizu, T Ohno… - Cancer research, 2006 - AACR
Most gene expression profiling studies of mesothelioma have been based on relatively
small sample numbers, limiting their statistical power. We did Affymetrix U133A microarray …
small sample numbers, limiting their statistical power. We did Affymetrix U133A microarray …
Targeting integrin β4 for cancer and anti-angiogenic therapy
FG Giancotti - Trends in pharmacological sciences, 2007 - cell.com
The integrins play key roles in the signaling networks that drive pathological angiogenesis
and tumor progression. Integrin β4 is a laminin receptor upregulated in tumor cells and …
and tumor progression. Integrin β4 is a laminin receptor upregulated in tumor cells and …
The established and future biomarkers of malignant pleural mesothelioma
V Panou, M Vyberg, UM Weinreich, C Meristoudis… - Cancer treatment …, 2015 - Elsevier
Malignant pleural mesothelioma (MPM) is an asbestos-related cancer with a median
survival of 12 months. The MPM incidence is 1–6/100,000 and is increasing as a result of …
survival of 12 months. The MPM incidence is 1–6/100,000 and is increasing as a result of …
Molecular changes in mesothelioma with an impact on prognosis and treatment
D Jean, J Daubriac… - … of pathology & …, 2012 - meridian.allenpress.com
Context.—In recent decades, research on malignant pleural mesothelioma (MPM) has been
developed to improve patients' outcomes by increasing the level of confidence in MPM …
developed to improve patients' outcomes by increasing the level of confidence in MPM …
Cytogenetic and molecular genetic changes in malignant mesothelioma
M Musti, E Kettunen, S Dragonieri, P Lindholm… - Cancer genetics and …, 2006 - Elsevier
Malignant mesothelioma (MM) results from the accumulation of a number of acquired
genetic events, especially deletions, which lead to the inactivation of multiple onco …
genetic events, especially deletions, which lead to the inactivation of multiple onco …
Spatial and molecular resolution of diffuse malignant mesothelioma heterogeneity by integrating label-free FTIR imaging, laser capture microdissection and …
F Großerueschkamp, T Bracht, HC Diehl, C Kuepper… - Scientific reports, 2017 - nature.com
Diffuse malignant mesothelioma (DMM) is a heterogeneous malignant neoplasia
manifesting with three subtypes: epithelioid, sarcomatoid and biphasic. DMM exhibit a high …
manifesting with three subtypes: epithelioid, sarcomatoid and biphasic. DMM exhibit a high …
[HTML][HTML] Analysis of differentially expressed genes, clinical value and biological pathways in prostate cancer
Z He, F Tang, Z Lu, Y Huang, H Lei, Z Li… - American journal of …, 2018 - ncbi.nlm.nih.gov
Analysis of differentially expressed genes, clinical value and biological pathways in prostate
cancer - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage …
cancer - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage …